UM

Browse/Search Results:  1-9 of 9 Help

Selected(0)Clear Items/Page:    Sort:
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Journal article
Ye,Zi Han, Yu,Wei Bang, Huang,Mu Yang, Chen,Jun, Lu,Jin Jian. Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives[J]. Acta Pharmaceutica Sinica B, 2023, 13(4), 1467-1487.
Authors:  Ye,Zi Han;  Yu,Wei Bang;  Huang,Mu Yang;  Chen,Jun;  Lu,Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date:2023/08/03
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
Building on the backbone of CD47-based therapy in cancer: Combination strategies, mechanisms, and future perspectives Review article
2023
Authors:  Ye, Zi Han;  Yu, Wei Bang;  Huang, Mu Yang;  Chen, Jun;  Lu, Jin Jian
Favorite | TC[WOS]:9 TC[Scopus]:10  IF:14.7/14.1 | Submit date:2023/05/02
Bispecific Antibodies  Cancer  Cd47  Clinical Data  Combination Strategies  Future Perspectives  Mechanisms  Preclinical Data  
CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer Journal article
Wei-Bang Yu, Yu-Chi Chen,, Can-Yu Huang, Zi-Han Ye, Wei Shi, Hong Zhu, Jia-Jie Shi, Jun Chen, Jin-Jian Lu. CD47 blockade improves the therapeutic effect of osimertinib in non-small cell lung cancer[J]. Frontiers of Medicine, 2022, 17(1), 105-118.
Authors:  Wei-Bang Yu;  Yu-Chi Chen,;  Can-Yu Huang;  Zi-Han Ye;  Wei Shi; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:3.9/5.4 | Submit date:2023/01/30
Adcp  Anti-cd47 Antibody  Combination Strategy  Egfr  Osimertinib  
Mitochondrial toxicity evaluation of traditional Chinese medicine injections with a dual in vitro approach Journal article
Shen, Yunfu, Guo, Kaiqiang, Ma, Aijun, Huang, Zhe, Du, Jingjing, Chen, Junhe, Lin, Qianyu, Wei, Chengming, Wang, Zi, Zhang, Fuming, Zhang, Juan, Lin, Wanjun, Feng, Na, Ma, Wenzhe. Mitochondrial toxicity evaluation of traditional Chinese medicine injections with a dual in vitro approach[J]. Frontiers in Pharmacology, 2022, 13.
Authors:  Shen, Yunfu;  Guo, Kaiqiang;  Ma, Aijun;  Huang, Zhe;  Du, Jingjing; et al.
Favorite | TC[WOS]:1 TC[Scopus]:3  IF:4.4/5.0 | Submit date:2023/01/31
Adverse Drug Reactions  Glucose/galactose Assay  Hepg2 Cells  Mitochondrial Toxicity  Tcm Injections  
A universal strategy for the fabrication of single-photon and multiphoton NIR nanoparticles by loading organic dyes into water-soluble polymer nanosponges Journal article
Yang, Li Xing, Liu, Yu Cheng, Cho, Chang Hui, Chen, Yi Rou, Yang, Chan Shan, Lu, Yin Lin, Zhang, Zhiming, Tsai, Yi Tseng, Chin, Yu Cheng, Yu, Jiashing, Pan, Hsiu Min, Jiang, Wei Rou, Chia, Zi Chun, Huang, Wei Shiang, Chiu, Yu Lin, Sun, Chun Kai, Huang, Yu Ting, Chen, Li Ming, Wong, Ken Tsung, Huang, Han Min, Chen, Chih Hsin, Chang, Yuan Jay, Huang, Chih Chia, Liu, Tzu Ming. A universal strategy for the fabrication of single-photon and multiphoton NIR nanoparticles by loading organic dyes into water-soluble polymer nanosponges[J]. Journal of Nanobiotechnology, 2022, 20, 311.
Authors:  Yang, Li Xing;  Liu, Yu Cheng;  Cho, Chang Hui;  Chen, Yi Rou;  Yang, Chan Shan; et al.
Adobe PDF | Favorite | TC[WOS]:7 TC[Scopus]:7  IF:10.6/11.4 | Submit date:2022/08/02
Fluorescence Imaging  Multiphoton Microscopy  Near-infraRed Red  Optoelectronic Material  Photodynamic Therapy  Polymer  Theranostic  
Regulation of CD47 expression by interferon-gamma in cancer cells Journal article
Ye, Zi Han, Jiang, Xiao Ming, Huang, Mu Yang, Xu, Yu Lian, Chen, Yu Chi, Yuan, Luo Wei, Huang, Can Yu, Yu, Wei Bang, Chen, Xiuping, Lu, Jin Jian. Regulation of CD47 expression by interferon-gamma in cancer cells[J]. Translational Oncology, 2021, 14(9), 101162.
Authors:  Ye, Zi Han;  Jiang, Xiao Ming;  Huang, Mu Yang;  Xu, Yu Lian;  Chen, Yu Chi; et al.
Favorite | TC[WOS]:15 TC[Scopus]:19  IF:4.5/4.2 | Submit date:2021/12/08
Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats Journal article
Li, Qiao Ping, Dou, Yao Xing, Huang, Zi Wei, Chen, Han Bin, Li, Yu Cui, Chen, Jian Nan, Liu, Yu Hong, Huang, Xiao Qi, Zeng, Hui Fang, Yang, Xiao Bo, Su, Zi Ren, Xie, Jian Hui. Therapeutic effect of oxyberberine on obese non-alcoholic fatty liver disease rats[J]. Phytomedicine, 2021, 85, 153550.
Authors:  Li, Qiao Ping;  Dou, Yao Xing;  Huang, Zi Wei;  Chen, Han Bin;  Li, Yu Cui; et al.
Favorite | TC[WOS]:34 TC[Scopus]:36  IF:6.7/6.2 | Submit date:2021/12/07
Ampk Signaling Pathway  Berberine  Insulin Signaling Pathway  Non-alcoholic Fatty Liver Disease  Obesity  Oxyberberine  
Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells Journal article
Yuan,Luo Wei, Jiang,Xiao Ming, Xu,Yu Lian, Huang,Mu Yang, Chen,Yu Chi, Yu,Wei Bang, Su,Min Xia, Ye,Zi Han, Chen,Xiuping, Wang,Yitao, Lu,Jin Jian. Licochalcone A inhibits interferon-gamma-induced programmed death-ligand 1 in lung cancer cells[J]. Phytomedicine, 2021, 80(153394).
Authors:  Yuan,Luo Wei;  Jiang,Xiao Ming;  Xu,Yu Lian;  Huang,Mu Yang;  Chen,Yu Chi; et al.
Favorite | TC[WOS]:33 TC[Scopus]:36  IF:6.7/6.2 | Submit date:2021/03/01
Pd-l1  Ifn-γ  Natural Products  Licochalcone a  Protein Synthesis Inhibitor  Ros  
TGFβ2-mediated epithelial–mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance Journal article
Jiang,Xiao ming, Xu,Yu lian, Yuan,Luo wei, Zhang,Le le, Huang,Mu yang, Ye,Zi han, Su,Min xia, Chen,Xiu ping, Zhu,Hong, Ye,Richard D., Lu,Jin jian. TGFβ2-mediated epithelial–mesenchymal transition and NF-κB pathway activation contribute to osimertinib resistance[J]. Acta Pharmacologica Sinica, 2020, 42(3), 451-459.
Authors:  Jiang,Xiao ming;  Xu,Yu lian;  Yuan,Luo wei;  Zhang,Le le;  Huang,Mu yang; et al.
Favorite | TC[WOS]:40 TC[Scopus]:39  IF:6.9/7.6 | Submit date:2021/03/01
Egfr Mutant Non-small Cell Lung Cancer  Emt  Nf-κb  Osimertinib Resistance  Tgfβ2